Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

80.54
Delayed Data
As of Aug 28
 +4.46 / +5.86%
Today’s Change
39.45
Today|||52-Week Range
102.28
+43.82%
Year-to-Date
No recent news for Clovis Oncology Inc.

Today’s Trading

Previous close76.08
Today’s open75.57
Day’s range75.57 - 80.76
Volume677,739
Average volume (3 months)657,924
Market cap$3.1B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-60.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales139.29
Price/Book8.25

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-1.57-3.57%
PBYIPuma Biotechnology I...+6.21+7.01%
WXWuXi PharmaTech (Cay...-0.20-0.47%
CBPOChina Biologic Produ...+0.37+0.37%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$2.08
Annual revenue (last year)$13.6M
Annual profit (last year)-$160.0M
Net profit margin-1,174.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial Officer, Secretary &
Executive VP
Erle T. Mast
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers